Clindamycin and nicotinic neuromuscular transmission.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10577648.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Upon clindamycin treatment a patient with Parkinson's disease showed marked tremor improvement which may be explained by clindamycin's ability to inhibit in-vitro nicotinergic, but not muscarinic signal transmission.
Medical subject headings
- Anti-Bacterial Agents
- Clindamycin
- Parkinson Disease
- Receptors, Muscarinic
- Receptors, Nicotinic
- Synaptic Transmission